AMENDMENT NO. 2 TO AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
Exhibit 4.1.2
AMENDMENT NO. 2
TO
AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
This Amendment No. 2 to Amended and Restated Stockholders Agreement (this Amendment), is made and entered into effective as of November 7, 2011, by and among Radius Health, Inc., a Delaware corporation (the Company), and the undersigned stockholders of the Company party to the Amended and Restated Stockholders Agreement, dated as of May 17, 2011, by and among the Company and the stockholders named therein (as amended, the Agreement). All capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed thereto in the Agreement.
WHEREAS, the Company and the undersigned parties to the Agreement, comprising the Majority Investors, desire to (i) amend the Agreement in order to specify restrictions on the sale by Stockholders of shares of the Companys capital stock, (ii) confirm that the Company has complied with its obligations under the Agreement relating to the Registration Statement on Form S-1 (Reg. No. 333-175091) originally filed with the Commission on June 23, 2011 (as amended, the Form S-1), (iii) in accordance with its obligations to two option holders, grant certain registration rights under the Agreement to such individuals and (iv) permit additional holders of the Companys securities to become parties to, and subject to, the Agreement.
NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
1. Clause (C) of Section 3.11(b) of the Agreement is hereby amended and restated in its entirety to read as follows:
(C) in no event shall any Stockholder be permitted, during the period commencing on the date hereof and ending on the date of the listing of the Common Stock on a national securities exchange, to sell, assign, transfer, make a short sale of, loan, grant any option for the purchase of, any shares of Common Stock for a price that is less than $8.142 per share (subject to proportionate and equitable adjustment upon any stock split, stock dividend, reverse stock split or similar event affecting the Common Stock that becomes effective after the date of this Agreement) or any other shares of capital stock of the Company for an effective price that is less than $8.142 per share on an as-converted to Common Stock basis (subject to proportionate and equitable adjustment upon any stock split, stock dividend, reverse stock split or similar event affecting the Common Stock that becomes effective after the date of this Agreement), except (x) with the prior written consent of the Company or (y) to a member of such Stockholders Group.
2. Upon, and subject to, the effectiveness of the Form S-1 on or prior to November 14, 2011, the Company shall have complied with all of its obligations under Section 3.4(a)(ii) of the Agreement with respect to the Registration Statement, no Event shall have occurred and the Company shall have no liability or obligation to pay any damages under the Agreement with
respect to such Registration Statement. Notwithstanding the terms of Section 3.4(a)(iii), the Registrable Securities to be included in the Registration Statement shall be allocated in the manner they will have been allocated in the Form S-1.
3. Solely of the purposes of Sections 3.4 through 3.12 of the Agreement, the shares of Common Stock issuable upon the exercise of the stock options issued to Alan H. Auerbach prior to the date hereof or upon the exercise of any stock options issued to Kurt C. Graves prior to November 30, 2011 shall be Registrable Securities as if such shares of Common Stock were Series A-1 Conversion Shares, and shall engender to each of Mr. Auerbach and Mr. Graves, as the case may be, the rights and obligations under the terms of Sections 3.4 through Section 3.12 of the Agreement (but not any other section of the Agreement) attributable to holders of Series A-1 Preferred Stock.
4. Notwithstanding anything in the Agreement to the contrary, any holder of shares of capital stock of the Company or other securities of the Company may become a party to the Agreement following the delivery to, and written acceptance by, the Company of an executed Instrument of Adherence to the Agreement substantially in the form attached to the Agreement as Annex C. No action or consent by Stockholder parties to the Agreement shall be required for such joinder to the Agreement by such holder, so long as such holder has agreed in writing to be bound by all of the obligations as a Stockholder party under the Agreement as indicated in the Instrument of Adherence and the Instrument of Adherence has been accepted by the Company. Notwithstanding anything in the Agreement to the contrary, any holder of shares of capital stock of the Company or other securities of the Company may become a party to the Agreement by executing and delivering to the Company this Amendment, and no action or consent by Stockholder parties to the Agreement shall be required for such joinder to the Agreement.
5. Each party to this Amendment that was not a party to the Agreement prior to its execution of this Amendment (an Additional Party) hereby agrees that such Additional Party, (i) in the case of a holder of Common Stock, has become a party and subject to the Agreement (as amended by this Amendment) in the capacity of a Common Stockholder and Stockholder, (ii) in the case of a holder of an option to purchase Common Stock, effective upon the exercise of such option, shall be a party and subject to the Agreement (as amended by this Amendment) in the capacity of a Common Stockholder and Stockholder, (iii) in the case of a holder of a warrant to purchase shares of Preferred Stock, effective upon the exercise of such warrant, shall be a party and subject to the Agreement (as amended by this Amendment) in the capacity of a Stockholder, and in each case shall be deemed to have made all of the representations and warranties made by a Stockholder under the Agreement.
6. Except as modified by this Amendment, the Agreement is hereby reaffirmed in its entirety by the Stockholders and shall continue in full force and effect. This Amendment shall be construed and enforced in accordance with and governed by the laws of the Commonwealth of Massachusetts, without giving effect to the principles of conflicts of laws thereof that would result in the application of the laws of any other jurisdiction. This Amendment may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
[remainder of page intentionally left blank; signatures follow]
IN WITNESS WHEREOF, each of the undersigned has caused this Amendment to be duly executed on its behalf as of the day and year first above written.
|
| RADIUS HEALTH, INC. | ||
|
|
| ||
|
|
| ||
|
| By: | /s/ C. Richard Edmund Lyttle | |
|
|
| C. Richard Edmund Lyttle, President | |
|
|
| ||
STOCKHOLDERS: |
|
| ||
|
|
| ||
MPM BIOVENTURES III, L.P. |
|
| ||
By: | MPM BioVentures III GP, L.P., its General Partner |
|
| |
By: | MPM BioVentures III LLC, its General Partner |
|
| |
|
|
| ||
By: | /s/ Ansbert K. Gadicke |
|
| |
| Ansbert K. Gadicke, Series A Member |
|
| |
|
|
| ||
MPM BIOVENTURES III-QP, L.P. |
|
| ||
By: | MPM BioVentures III GP, L.P., its General Partner |
|
| |
By: | MPM BioVentures III LLC, its General Partner |
|
| |
|
|
|
| |
By: | /s/ Ansbert K. Gadicke |
|
| |
| Ansbert K. Gadicke, Series A Member |
|
| |
|
|
| ||
MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG |
|
| ||
By: | MPM BioVentures III GP, L.P., in its |
|
| |
| capacity as the Managing Limited Partner |
|
| |
By: | MPM BioVentures III LLC, its General Partner |
|
| |
|
|
|
| |
By: | /s/ Ansbert K. Gadicke |
|
| |
| Ansbert K. Gadicke, Series A Member |
|
| |
|
|
| ||
MPM BIOVENTURES III PARALLEL FUND, L.P. |
|
| ||
By: MPM BioVentures III GP, L.P., its General Partner |
|
| ||
By: MPM BioVentures III LLC, its General Partner |
|
| ||
|
|
| ||
By: | /s/ Ansbert K. Gadicke |
|
| |
| Ansbert K. Gadicke, Series A Member |
|
| |
|
|
| ||
MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC |
|
| ||
|
|
| ||
By: | /s/ Ansbert K. Gadicke |
|
| |
| Ansbert K. Gadicke, Manager |
|
|
[Signature page to Amendment No. 2 to Amended and Restated Stockholders Agreement]
MPM BIO IV NVS STRATEGIC FUND, L.P. |
|
| |
By: MPM BioVentures IV GP LLC, its General Partner |
|
| |
By: MPM BioVentures IV LLC, its Managing Member |
|
| |
|
|
| |
By: | /s/ Ansbert K. Gadicke |
|
|
| Ansbert K. Gadicke, Member |
|
|
|
|
| |
|
|
| |
BB BIOTECH VENTURES II, L.P. |
|
| |
|
|
| |
|
|
| |
By: | /s/ Pascal Mahieux |
|
|
Name: Pascal Mahieux |
|
| |
Title: |
|
| |
|
|
| |
BB BIOTECH GROWTH N.V. |
|
| |
|
|
| |
|
|
| |
By: | /s/ H.J. van Neutegem |
|
|
Name: H.J. van Neutegem |
|
| |
Title: Managing Director |
|
| |
|
|
| |
BROOKSIDE CAPITAL PARTNERS FUND, L.P. |
|
| |
|
|
| |
|
|
| |
By: | /s/ Ranesh Ramanathan |
|
|
Name: Ranesh Ramanathan |
|
| |
Title: General Counsel |
|
| |
|
|
| |
|
|
| |
THE WELLCOME TRUST LIMITED, |
|
| |
AS TRUSTEE OF THE WELLCOME TRUST |
|
| |
|
|
| |
|
|
| |
By: | /s/ Peter J. Pereira Gray |
|
|
Name: Peter J. Pereira Gray |
|
| |
Title: Managing Director, Investment Division |
|
|
[Signature page to Amendment No. 2 to Amended and Restated Stockholders Agreement]
OBP IV HOLDINGS LLC |
|
| |
By: OBP Management IV, L.P. |
|
| |
|
|
|
|
|
|
|
|
By: | /s/ Jonathan J. Fleming |
|
|
Name: Jonathan J. Fleming |
|
| |
Title: General Partner |
|
| |
|
|
|
|
|
|
|
|
MRNA II - HOLDINGS LLC |
|
| |
By: OBP Management IV, L.P. |
|
| |
|
|
|
|
|
|
|
|
By: | /s/ Jonathan J. Fleming |
|
|
Name: Jonathan J. Fleming |
|
| |
Title: General Partner |
|
| |
|
|
|
|
|
|
|
|
HEALTHCARE VENTURES VII, LP, |
|
| |
By: HealthCare Partners VII, L.P. |
|
| |
Its General Partner |
|
| |
|
|
|
|
By: | /s/ Jeffrey Steinberg |
|
|
Name: Jeffrey Steinberg |
|
| |
Title: Administrative Partner of HealthCare Partners VII, L.P. |
|
| |
The General Partner of HealthCare Ventures VII, L.P. |
|
| |
|
|
|
|
|
|
|
|
/s/ Raymond F. Schniazi |
|
| |
Dr. Raymond F. Schinazi |
|
| |
|
|
| |
|
|
| |
HEALTHCARE PRIVATE EQUITY LIMITED PARTNERSHIP |
|
| |
By: Waverley Healthcare Private Equity |
|
| |
Limited, its general partner |
|
| |
|
|
|
|
By: | /s/ Archie Struthers |
|
|
Name: Archie Struthers |
|
| |
Title: Director |
|
|
[Signature page to Amendment No. 2 to Amended and Restated Stockholders Agreement]
The Breining Family Trust dated August 15, 2003 |
|
| |
|
|
|
|
|
|
|
|
By: | /s/ Clifford Breining |
|
|
Name: Clifford Breining |
|
| |
Title: Trustee |
|
| |
|
|
| |
|
|
| |
/s/ Dennis Carson |
|
| |
Dr. Dennis A. Carson |
|
| |
|
|
| |
|
|
| |
David E. Thompson Revocable Trust |
|
| |
|
|
|
|
|
|
|
|
By: | /s/ David E. Thompson |
|
|
Name: David E. Thompson |
|
| |
Title: Trustee |
|
| |
|
|
| |
|
|
| |
Jonnie K. Westbrook Revocable Trust dated March 17, 2000 |
|
| |
|
|
|
|
|
|
|
|
By: | /s/ Jonnie K. Westbrook |
|
|
Name: Jonnie K. Westbrook |
|
| |
Title: Trustee |
|
| |
|
|
| |
|
|
| |
H. Watt Gregory Watt |
|
| |
H. Watt Gregory III |
|
| |
|
|
| |
|
|
| |
Hostetler Family Trust UTD 3/18/92 |
|
| |
|
|
|
|
|
|
|
|
By: | /s/ Karl Y. Hostetler |
|
|
Name: Karl Y. Hostetler |
|
| |
Title: Co-Trustee |
|
| |
|
|
|
|
By: | /s/ Maragarethe Hostetler |
|
|
Name: Margarethe Hostetler |
|
| |
Title: Co-Trustee |
|
|
[Signature page to Amendment No. 2 to Amended and Restated Stockholders Agreement]
The Richman Trust dated 2/6/83 |
| |
|
| |
|
|
|
By: | /s/ Douglas D. Richman |
|
Name: | Douglas D. Richman |
|
Title: | Co-Trustee |
|
|
|
|
By: | /s/ Eva A. Richman |
|
Name: | Eva A. Richman, |
|
Title: | Co-Trustee |
|
|
| |
|
| |
Ruff Trust dated l-1-02 |
| |
|
|
|
By: | /s/ F. Bronson van Wyck |
|
Name: | F. Bronson Van Wyck |
|
Title: | Trustee |
|
|
| |
|
| |
IPSEN PHARMA SAS |
| |
|
|
|
By: | /s/ Nathalie Joannes |
|
Name: | Nathalie Joannes |
|
Title: | Executive Vice President, General Counsel |
|
|
| |
|
| |
NORDIC BIOSCIENCE CLINICAL |
| |
DEVELOPMENT VII A/A |
| |
|
| |
|
|
|
By: | /s/ Thomas Nielsen |
|
Name: | Thomas Nielsen |
|
Title: | CFO |
|
|
| |
|
| |
/s/ Alwyn Michael Parfitt |
| |
Alwyn Michael Parfitt, M.D. |
| |
|
| |
|
| |
/s/ Barnett Pitzele |
| |
Barnett Pitzele |
|
[Signature page to Amendment No. 2 to Amended and Restated Stockholders Agreement]
/s/ Bart Henderson |
| |
Bart Henderson |
| |
|
| |
|
| |
/s/ Benjamin C. Lane |
| |
Benjamin C. Lane |
| |
|
| |
|
| |
BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS | ||
|
|
|
By: | /s/ Michael G. Douglas |
|
Name: | Michael G. Douglas, Ph.D. |
|
Title: | Director, UAMS BioVentures |
|
|
| |
|
| |
/s/ Brian Nicholas Harvey |
| |
Brian Nicholas Harvey |
| |
|
| |
|
| |
/s/ Cecil Richard Lyttle |
| |
Cecil Richard Lyttle |
| |
|
| |
|
| |
/s/ Charles OBrien |
| |
Charles OBrien, PhD. |
| |
|
| |
/s/ Chris Glass |
| |
Chris Glass |
| |
|
| |
|
| |
/s/ Christopher Miller |
| |
Christopher Miller |
| |
|
| |
|
| |
/s/ Daniel F. McCarthy |
| |
Daniel F. McCarthy |
| |
|
| |
|
| |
/s/ Dotty Paquin |
| |
Dotty Paquin |
| |
|
| |
|
| |
/s/ Edith Estabrook |
| |
Edith Estabrook |
|
[Signature page to Amendment No. 2 to Amended and Restated Stockholders Agreement]
/s/ Elizabeth Czerepak |
| |
Elizabeth Czerepak |
| |
|
| |
|
| |
/s/ Gary Hattersley |
| |
Gary Hattersley |
| |
|
| |
|
| |
H2 ENTERPRISES, LLC |
| |
|
|
|
By: | /s/ H. Watt Gregory, III |
|
Name: | H. Watt Gregory, III |
|
Title: | Managing Member |
|
|
| |
|
| |
Dr. John Potts, Jr and Susanne K. Potts |
| |
Irrevocable Trust for Stephen K. Potts |
| |
dated 6-15-05 |
| |
|
| |
|
|
|
By: | /s/ John T. Potts |
|
Name: | John T. Potts Jr. M.D. |
|
Title: | Director of Research & Physician-in Chief-Emeritus, Massachusetts General Hospital | |
|
| |
|
| |
/s/ John Thomas Potts |
| |
John Thomas Potts, M.D. |
| |
|
| |
|
| |
/s/ John A. Katzenellenbogen |
| |
John A. Katzenellenbogen, PhD. |
| |
|
| |
|
| |
John A. Katzenellenbogen Trust |
| |
Under Agreement Dated August 2, 1999 |
| |
|
|
|
By: | /s/ John A. Katzenellenbogen |
|
Name: | John A. Katzenellenbogen |
|
Title: | Trustee |
|
|
| |
|
| |
/s/ Benita S. Katzenellenbogen |
| |
Benita S. Katzenellenbogen, PhD |
| |
|
| |
/s/ E. Kelly Sullivan |
| |
E. Kelly Sullivan |
|
[Signature page to Amendment No. 2 to Amended and Restated Stockholders Agreement]
/s/ Jonathan Guerriero |
|
Jonathan Guerriero |
|
|
|
|
|
/s/ Julianne Glowacki |
|
Julianne Glowacki |
|
|
|
|
|
/s/ Kathy Welch |
|
Kathy Welch |
|
|
|
|
|
/s/ Kelly Colbourn |
|
Kelly Colbourn |
|
|
|
|
|
/s/ Louis O Dea |
|
Louis ODea |
|
|
|
|
|
/s/ Maria Grunwald |
|
Maria Grunwald |
|
|
|
|
|
/s/ Mary Lumpkins |
|
Mary Lumpkins |
|
|
|
|
|
/s/ Maysoun Shomali |
|
Maysoun Shomali |
|
|
|
|
|
/s/ Micahel Rosenblatt |
|
Michael Rosenblatt, M.D. |
|
|
|
|
|
/s/ Patricia Rosenblatt |
|
Patricia E. Rosenblatt |
|
|
|
|
|
/s/ Robert L. Jilka |
|
Robert L. Jilka, PhD. |
|
[Signature page to Amendment No. 2 to Amended and Restated Stockholders Agreement]
/s/ Robert S. Weinstein |
| |
Robert S. Weinstein, M.D. |
| |
|
| |
|
| |
/s/ Samuel Ho |
| |
Samuel Ho |
| |
|
| |
|
| |
/s/ Socrates E. Papaoulous |
| |
Socrates E. Papapoulos, M.D. |
| |
|
| |
|
| |
/s/ Stavros C. Manolagas |
| |
Stavros C. Manolagas |
| |
|
| |
|
| |
/s/ Stavroula Kousteni |
| |
Stavroula Kousteni, PhD. |
| |
|
| |
/s/ Teresita M. Bellido |
| |
Teresita M. Bellido, PhD. |
| |
|
| |
|
| |
/s/ Thomas E. Sparks |
| |
Thomas E. Sparks |
| |
|
| |
|
| |
/s/ Tonya D. Goss |
| |
Tonya D. Goss |
| |
|
| |
The Kent C. Westbrook Revocable Trust, |
| |
Dated March 17, 2000, |
| |
Kent C. Westbrook, Trustee |
| |
|
|
|
By: | /s/ Kent C. Westbrook |
|
Name: | Kent C. Westbrook |
|
Title: | Trustee |
|
|
| |
|
| |
GE CAPITAL EQUITY INVESTMENTS, INC. |
| |
|
| |
|
|
|
By: | /s/ Jacqueline Blechinger |
|
Name: | Jacqueline Blechinger |
|
Title: | Duly Authorized Signatory |
|
[Signature page to Amendment No. 2 to Amended and Restated Stockholders Agreement]
OXFORD FINANCE LLC |
| |
|
| |
|
|
|
By: | /s/ John G. Henderson |
|
Name: | John G. Henderson |
|
Title: | Vice President & General Counsel |
|
|
| |
|
| |
LEERINK SWANN LLC |
| |
|
| |
|
|
|
By: | /s/ Donald D. Notman |
|
Name: | Donald D. Notman |
|
Title: | Managing Director |
|
|
| |
|
| |
SVB FINANCIAL GROUP |
| |
|
| |
|
|
|
By: | /s/ Michael Kruse |
|
Name: | Michael Kruse |
|
Title: | Treasurer |
|
[Signature page to Amendment No. 2 to Amended and Restated Stockholders Agreement]